NASDAQ:CGNX - Cognex Stock Price, Price Target & More

Cognex trades on the NASDAQ under the ticker symbol "CGNX."

Cognex declared a quarterly dividend on Monday, April 30th. Investors of record on Friday, May 18th will be given a dividend of $0.045 per share on Friday, June 1st. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date is Thursday, May 17th. View Cognex's Dividend History.

Shares of Cognex split before market open on Monday, December 4th 2017. The 2-1 split was announced on Monday, October 30th 2017. The newly created shares were issued to shareholders after the market closes on Friday, December 1st 2017. An investor that had 100 shares of Cognex stock prior to the split would have 200 shares after the split.

Cognex declared that its board has authorized a share repurchase plan on Friday, February 16th 2018, which allows the company to repurchase $150,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board of directors believes its stock is undervalued.

Cognex Co. (NASDAQ:CGNX) posted its earnings results on Thursday, February, 15th. The scientific and technical instruments company reported $0.30 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.25 by $0.05. The scientific and technical instruments company had revenue of $180.37 million for the quarter, compared to the consensus estimate of $178.75 million. Cognex had a net margin of 21.56% and a return on equity of 23.08%. The business's quarterly revenue was up 39.5% on a year-over-year basis. During the same period last year, the business earned $0.20 earnings per share. View Cognex's Earnings History.

Cognex is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Cognex.

9 equities research analysts have issued 12 month price objectives for Cognex's stock. Their forecasts range from $40.00 to $80.00. On average, they anticipate Cognex's stock price to reach $57.4167 in the next year. View Analyst Ratings for Cognex.

Cognex saw a drop in short interest in May. As of May 31st, there was short interest totalling 8,317,405 shares, a drop of 16.8% from the May 15th total of 9,992,092 shares. Based on an average daily volume of 1,428,495 shares, the days-to-cover ratio is presently 5.8 days. Approximately 5.0% of the shares of the company are sold short. View Cognex's Current Options Chain.

Some companies that are related to Cognex include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Sensata Technologies (ST), MKS Instruments (MKSI), Orbotech (ORBK), Esterline Technologies (ESL), Rudolph Technologies (RTEC), Mesa Laboratories (MLAB), Hurco Companies (HURC), Universal Detection Technology (UNDT), Clearsign Combustion (CLIR), Sypris Solutions (SYPR), International Isotopes (INIS) and Elbit Vision Systems (EVSNF).

News coverage about CGNX stock has been trending somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Cognex earned a coverage optimism score of 0.15 on Accern's scale. They also gave news coverage about the scientific and technical instruments company an impact score of 46.23 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Cognex's stock is owned by a number of of retail and institutional investors. Top institutional investors include BlackRock Inc. (9.66%), Neuberger Berman Group LLC (2.01%), Franklin Resources Inc. (1.52%), OppenheimerFunds Inc. (1.46%), Eagle Asset Management Inc. (1.37%) and Bamco Inc. NY (1.07%). Company insiders that own Cognex stock include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Richard Morin, Robert Willett and Theodor Krantz. View Institutional Ownership Trends for Cognex.

CGNX stock was sold by a variety of institutional investors in the last quarter, including Barclays PLC, Carillon Tower Advisers Inc., Eagle Asset Management Inc., Prudential Financial Inc., OppenheimerFunds Inc., Artisan Partners Limited Partnership, Federated Investors Inc. PA and Millennium Management LLC. Company insiders that have sold Cognex company stock in the last year include Anthony Sun, Bruce Robinson J, Jeffrey Benjamin Miller, Jerry A Schneider, John J Curran, Patrick Alias, Robert Willett and Theodor Krantz. View Insider Buying and Selling for Cognex.

CGNX stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Old Mutual Global Investors UK Ltd., Franklin Resources Inc., Ownership Capital B.V., Legal & General Group Plc, Baird Financial Group Inc., Allianz Asset Management GmbH and Allianz Asset Management GmbH. View Insider Buying and Selling for Cognex.

Shares of CGNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CGNX stock can currently be purchased for approximately $45.11.

Cognex has a market capitalization of $7.86 billion and generates $747.95 million in revenue each year. The scientific and technical instruments company earns $177.17 million in net income (profit) each year or $1.45 on an earnings per share basis. Cognex employs 1,771 workers across the globe.

Cognex's mailing address is ONE VISION DRIVE, NATICK MA, 01760. The scientific and technical instruments company can be reached via phone at 508-650-3000 or via email at [email protected]